Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A randomized phase II trial of 3 regimens in the treatment of relapsed or refractory acute myeloid leukemia (AML) in adults: A CALGB study

A randomized phase II trial of 3 regimens in the treatment of relapsed or refractory acute myeloid leukemia (AML) in adults: A CALGB study. ASH. 1990; 294a (#1166).


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.